This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Indian Railways: Building a Permanent Legacy
Musacchio, Aldo; Khanna, Tarun; Tahilyani, RachnaCase HBS-710008-EEconomicsTo maximize their effectiveness, color cases should be printed in color.Starting at €8.20
-
Nokia: The Burning Platform
Alcacer, Juan; Khanna, Tarun; Furey, MaryCase HBS-711514-EStrategyTo maximize their effectiveness, color cases should be printed in color. Overview on the state of Nokia since the "Emerging Nokia?" case was written.Starting at €8.20
-
Emerging Markets: Look Before You Leap
Khanna, Tarun; Palepu, KrishnaArticle ART-2385-EStrategyThink "emerging markets," and most people think BRICs. The problem with this approach is that it is too simplistic and tends to treat emerging markets as one homogeneous whole, when the exact opposite is true. Instead of asking, "What's my emerging market strategy for Brazil, Russia, India or China?" companies should ask themselves, "In which ways is this particular market emerging?" Viewed this way, the answer may surprise them. The authors synt...Starting at €8.20
-
Charles Schwab Corp. in 2017 - Teaching note
Siegel, R; Makinen, JTeaching Note SGSB-SM282TN-EStrategyBy almost any measure, Charles Schwab Corp. appeared to be killing it in 2017. The wealth management, banking, custody and brokerage firm’s stock was trading near its all-time high. It was posting unprecedented levels of new client accounts, net new client assets, revenues and profits and had a record $3.12 trillion in client assets under management. Schwab was taking customers and assets from old-line wire houses like Morgan Stanley, while fendi...Starting at €0.00
-
Charles Schwab Corp. in 2017
Siegel, R; Makinen, JCase SGSB-SM282-EStrategyBy almost any measure, Charles Schwab Corp. appeared to be killing it in 2017. The wealth management, banking, custody and brokerage firm’s stock was trading near its all-time high. It was posting unprecedented levels of new client accounts, net new client assets, revenues and profits and had a record $3.12 trillion in client assets under management. Schwab was taking customers and assets from old-line wire houses like Morgan Stanley, while fendi...Starting at €8.20
-
Tetra Pak Argentina
Khanna, Tarun; Palepu, Krishna G.; Herrero, Gustavo A.Case HBS-708402-EStrategyDeals with the hands-on management of a difficult situation facing the subsidiary of a multinational corporation (Tetra Pak) in a developing country (Argentina). The situation arises from a major economic, social, and institutional breakdown that jeopardizes the subsidiary's existence. Argentina defaulted on it sovereign debt and devalued the peso by over 200%, but it differentiated the treatment of the FX rate to be applied to various transactio...Starting at €8.20
-
HCL Technologies (B)
Hill, Linda A.; Khanna, TarunCase HBS-408006-EThis case is accompanied by a Video Short that can be shown in class or included in a digital coursepack. Instructors should consider the timing of making the video available to students, as it may reveal key case details. Supplements the (A) case.Starting at €5.74
-
Haier: Taking a Chinese Company Global in 2011
Khanna, Tarun; Palepu, Krishna G.; Andrews, PhillipCase HBS-712408-EStrategyIn 2011, Haier, China's leading appliance manufacturer, had over $20 billion in worldwide sales and had just been named the leading refrigerator manufacturer worldwide. This case describes Haier's rise over three decades, from a defunct refrigerator factory in China's Shandong province to an international player with $5.5 billion in overseas sales. Haier had followed a nontraditional expansion strategy of entering the developed markets of Europe ...Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
The Future of Patent Examination at the USPTO
Choudhury, Prithwiraj; Khanna, Tarun; Mehta, SarahCase HBS-617027-ELeadership and People ManagementThe U.S. Patent and Trademark Office (USPTO) is the federal government agency responsible for evaluating and granting patent and trademark applications. In 2015, the USPTO employed approximately 8,000 patent examiners who granted nearly 300,000 patents to inventors. As of April 2016, it took roughly 26 months for a patent application to move through the evaluation process, which exceeded the office's processing goal of 20 months. In August 2016,...Starting at €8.20